Enzyme-Linked Immunosorbent Assay (ELISA) Market to grow by USD 98.6 Billion from 2023-2028, driven by frequent diagnostic testing, Report on AI-powered market evolution - Technavio

The ELISA market thrives due to its critical role in vaccine development and clinical diagnostics. ELISA kits detect antibodies and antigens via antibody detection, essential for vaccines targeting diseases like HIV and hepatitis in infectious disease testing. The global rise in chronic conditions, such as cancer, boosts demand for diagnostic assays like sandwich ELISA and competitive ELISA. An aging population and frequent testing needs further drive growth, supported by investments in protein quantification and ELISA reagents.

Innovations in ELISA instruments and multiplex ELISA enhance efficiency, making ELISA technology vital for clinical diagnostics and research, propelling the market forward.

Challenges: Regulatory Hurdles and Cost Constraints

Stringent regulations for diagnostic assays approval delay launches, increasing costs for ELISA suppliers. High prices of advanced ELISA kits and ELISA reagents limit adoption in developing regions, requiring cost-effective solutions to sustain growth.

Market Trends: Automation and Multiplexing Gain Traction

Automation in ELISA instruments boosts efficiency for immunoassay testing, while multiplex ELISA saves time in protein quantification. Point-of-care ELISA technology enhances accessibility, and sustainable ELISA reagents align with eco-trends.

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Key Companies: Leaders Shaping the ELISA Market

The ELISA market is fragmented, with key players advancing immunoassay testing. Below are the leading companies:

• Thermo Fisher Scientific Inc.: A leader in ELISA suppliers, Thermo Fisher offers ELISA kits for protein quantification and infectious disease testing. Their automated ELISA instruments ensure high-sensitivity diagnostic assays, expanding via R&D and acquisitions.
• Bio-Rad Laboratories Inc.: Bio-Rad excels with multiplex ELISA solutions like Bio-Plex, enhancing sandwich ELISA for antibody detection. Their focus on clinical diagnostics and partnerships strengthens their role in ELISA technology.
• Agilent Technologies Inc.: Agilent’s Dako ELISA kits target infectious disease testing, including SARS-CoV-2 antibody detection. Their direct ELISA and indirect ELISA offerings cater to research and clinical diagnostics, bolstered by biotech collaborations.
• Merck KGaA: Merck’s MilliporeSigma provides ELISA reagents for competitive ELISA, widely used in protein quantification and cancer diagnostics. Their digital tools enhance ELISA technology, expanding reach among ELISA suppliers.
• PerkinElmer Inc.: PerkinElmer’s EUROIMMUN ELISA kits lead in autoimmune and infectious disease testing. Their automated ELISA instruments streamline diagnostic assays, aligning with eco-friendly trends in ELISA reagents.

These companies innovate with multiplex ELISA and cost-effective ELISA kits, meeting rising demand in clinical diagnostics.

Market Segmentation: Application, End-User, and Geography

The ELISA market is segmented as follows:

• By Application: Includes vaccine development, drug monitoring, immunology, and others. Vaccine development leads, driven by antibody detection in sandwich ELISA and ELISA technology.
• By End-User: Covers hospitals, diagnostic centers, and research labs. Hospitals dominate, using ELISA kits for routine infectious disease testing.
• By Geography: Spans North America, Europe, APAC, South America, and MEA. Asia holds a 34% growth share, fueled by R&D in ELISA instruments.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

About Technavio

Technavio is a leading global technology research and advisory company, providing actionable insights to help businesses identify market opportunities and develop effective strategies. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports, covering 800 technologies across 50 countries. Their client base includes enterprises of all sizes, including over 100 Fortune 500 companies, relying on Technavio’s comprehensive research to optimize their market positions.